GGrantIndex
Sort

15,440 grants matching organoids

High-Throughput Volumetric Photoacoustic Imaging of Living Vascularized Organoids

$494,644
Junjie Yao · Duke University · R01 · FY2021 · EB

STING-dependent Intestinal Regeneration upon Radiation Injury

$494,501
Jian Yu · University Of Southern California · R01 · FY2023 · CA

SCGE Disease Models Studies Supplement: Correction of RHO P23H adRP

$494,470
Kevin Dale Wells · University Of Missouri-Columbia · U42 · FY2022 · OD

Project 1

$494,343
Takao K Hensch · Harvard University · P50 · FY2019 · MH

Molecular Basis of Human Visual System Disorders

$494,331
Rui Chen · Baylor College Of Medicine · R01 · FY2019 · EY

Molecular Basis of Human Visual System Disorders

$494,331
Rui Chen · Baylor College Of Medicine · R01 · FY2020 · EY

Identifying pathogenic mechanisms underlying PACS1 Syndrome: implications for neural development

$494,281
Alicia Dione Guemez Gamboa · Northwestern University At Chicago · R01 · FY2024 · NS

Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin

$494,277
Konstantinos Votanopoulos · Wake Forest University Health Sciences · R01 · FY2023 · CA

dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community

$494,250
Jeffrey S. Grethe · University Of California, San Diego · U24 · FY2025 · DK

Ferroptosis and Ferroptotic Stress in Maladaptive Renal Repair

$494,142
Tomokazu Souma · Duke University · R01 · FY2025 · DK

Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin

$494,107
Konstantinos Votanopoulos · Wake Forest University Health Sciences · R01 · FY2025 · CA

Implementation of a vaginal/rectal HIV transmission to model to evaluate microbic

$494,098
J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R33 · FY2010 · AI

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases

$493,992
Matthew S Bogyo · Stanford University · R01 · FY2022 · DK

Polymerase epsilon-based mouse and derived organoid models of intestinal cancer

$493,934
Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2022 · CA

Using the GoFlowChip to understand SARS-CoV-2 infection of the gastrointestinal mucosa of humans and bats

$493,788
Seth T Walk · Montana State University - Bozeman · U01 · FY2020 · EB

Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment

$493,761
Benjamin Douglas Korman · University Of Rochester · R01 · FY2022 · AR

Integration of elasticity, viscosity, and plasticity in cellular mechanosensing

$493,741
Vivek Shenoy · University Of Pennsylvania · R01 · FY2025 · GM

Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer

$493,346
Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2023 · CA

Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer

$493,346
Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2022 · CA

Mechanisms of targeting cellular self-renewal in glioblastoma

$493,327
Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA

Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response

$493,245
Charles L Sawyers · Columbia University Health Sciences · P01 · FY2023 · CA

Conditionally Reprogrammed Cell Model for Castration-Resistant Prostate Cancer (CRPC)

$493,219
Xuefeng Liu · Georgetown University · R01 · FY2019 · CA

Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cells

$493,126
Mark M Huycke · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA

H. Pylori Relationship to Digestive Diseases and Cancer

$493,103
Richard M Peek · Vanderbilt University Medical Center · R01 · FY2024 · CA

Human Intestinal Organoids: Pre-Clinical Models of Non-Inflammatory Diarrhea

$492,975
Mark Donowitz · Johns Hopkins University · U18 · FY2012 · TR